Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin (5-HT) 2 receptor family, including 5-HT2A, 5-HT2B and 5-HT2C subtypes, are G protein-coupled receptors that mediate the effects of serotonin in the central and peripheral nervous systems. Activation of these receptors primarily couples via Gq/11 proteins, leading to activation of phospholipase C (PLC) and subsequent increases in intracellular calcium and activation of protein kinase C. These receptors are widely distributed throughout the brain and are involved in a variety of physiological functions, including mood regulation, cognition, and sensory perception. They are also targets for numerous drugs, including antipsychotics, antidepressants, and hallucinogens. Receptor levels can be regulated by developmental stage or pharmacological intervention.
Agonism or antagonism of 5-HT2 receptors, leading to modulation of downstream signaling pathways involving Gq/11 proteins, phospholipase C (PLC), inositol trisphosphate (IP3), diacylglycerol (DAG), protein kinase C (PKC), and intracellular calcium levels.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-HT2 Receptor Family (including 5-HT2A, 5-HT2B, and 5-HT2C subtypes) (5-HT2 Receptor Family).